🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
It is estimated that by 2016, nearly 50% of HIV-positive individuals in the...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2015-12
Trial ID
NCT03244488
Treatments Being Tested
To investigate the safety and tolerability of TC-5214 following oral admini...
Status
Completed
Location
Research Site
Start Date
2010-06
Trial ID
NCT01145768
This protocol evaluates the efficacy of combining pharmacologic treatments ...
Status
Completed
Location
Veterans Affairs Medical Center
Start Date
1997-01
Trial ID
NCT00018161
Treatments Being Tested
The objective of this study is to evaluate the efficacy of mecamylamine (ME...
Status
Completed
Location
VA Connecticut Healthcare System
Start Date
2007-08
Trial ID
NCT00563797
Treatments Being Tested
(Food versus no food) crossover study to measure the effects of food on pha...
Status
Completed
Location
Research Site
Start Date
2011-11
Trial ID
NCT01458899
Treatments Being Tested
The purpose of this study is to assess the safety and effect of TC-5214 as ...
Status
Terminated
Location
Research Site
Start Date
2011-02
Trial ID
NCT01288079
Treatments Being Tested
The purpose of this study is to determine if TC-5214 or placebo (a tablet t...
Status
Completed
Location
Research Site
Start Date
2010-06
Trial ID
NCT01157078
The purpose of the study will be to evaluate the efficacy of mecamylamine i...
Status
Completed
Location
VA Connecticut Healthcare System
Start Date
2004-05
Trial ID
NCT00342563
Treatments Being Tested
The purpose of this study is to determine if TC-5214 or placebo (a tablet t...
Status
Completed
Location
Research Site
Start Date
2010-09
Trial ID
NCT01180400
Many disorders where attentional problems are a hallmark, such as Alzheimer...
Status
Completed
Location
National Institute on Drug Abuse, Intramural Research Program
Start Date
2010-10
Trial ID
NCT01223404
Treatments Being Tested